Corylin是从Psoralea corylifolia L中分离出的一种酚类化合物，具有抗炎和免疫抑制特性。
Cas No.:53947-92-5
Sample solution is provided at 25 µL, 10mM.
_1-3.$$$39978408@51.jpg');)
_1-9.$$$38538795@65.jpg');)
_1-9.$$$39112701@51.jpg');)
_1-7.$$$37316672@70.jpg');)
_366-372.$$$36198801@70.jpg');)
.$$$38565142@65.jpg');)
_1867-1883.$$$33248023@67.jpg');)
_eads6055.$$$39977546@45.jpg');)
_eadm9805.$$$40080571@45.jpg');)
_eadj3020.$$$39666821@45.jpg');)
_1-20.$$$39757301@28.jpg');)
_1-24.$$$38898113@28.jpg');)
_273-287.$$$36806353@46.jpg');)
_1-16.$$$37156877@44.jpg');)
_1-19.$$$37460805@44.jpg');)
_1291-1307.$$$34518654@46.jpg');)
Corylin is a phenolic compound isolated from the Psoralea corylifolia L, with anti-inflammatory and immunosuppressive properties [1]. Corylin activates BAT and Beige adipocytes through SIRT1 and β3-AR regulation, exerting anti-obesity effect[2]. Corylin has been widely used to prolong the life span of aged mice under metabolic stress, improve physiological function, reduce metabolic stress and maintain tissue function[3].
In vitro, Corylin treatment for 24 hours significantly inhibited the proliferation of MCF-7 cells and MDA-MB-231 cells with IC50 values of 10.58µM and 13.59µM, respectively[4]. Treatment of RAW264.7 cells with 10µM Corylin for 24h inhibited cell viability and migration[5]. Pretreatment of BV2 cells with 10µM Corylin for 1 hour attenuated lipopolysaccharide (LPS) -induced inflammatory response, reduced TNF-α and IL-6 production, and inhibited MAPK phosphorylation[6].
In vivo, Corylin treatment via oral administration at a dose of 50mg/kg/day for 15 weeks reduced oxidative stress, VCAM-1 and NOX4 Expression, and atherosclerotic plaques in the thoracic aorta of cholesterol diet-treated mice[7]. Intraperitoneal injection of a single dose of Corylin (20mg/kg) for 12 hours significantly alleviated LPS-induced cardiac dysfunction and reduced inflammation in mice[8].
References:
[1] Qin Z, Li S, Yao Z, et al. Metabolic profiling of corylin in vivo and in vitro[J]. Journal of pharmaceutical and biomedical analysis, 2018, 155: 157-168.
[2] Chen C C, Kuo C H, Leu Y L, et al. Corylin reduces obesity and insulin resistance and promotes adipose tissue browning through SIRT-1 and β3-AR activation[J]. Pharmacological Research, 2021, 164: 105291.
[3] Wang T H, Tseng W C, Leu Y L, et al. The flavonoid corylin exhibits lifespan extension properties in mouse[J]. Nature communications, 2022, 13(1): 1238.
[4] Liu S, Wang L, Zhang R. Corylin suppresses metastasis of breast cancer cells by modulating miR-34c/LINC00963 target[J]. Libyan Journal of Medicine, 2021, 16(1): 1883224.
[5] Liu N, Yang Z, Yanzhang R, et al. Integrated analysis of Corylin from Psoralea Corylifolia inhibiting osteoporosis via MAPK pathway[J]. Scientific Reports, 2025, 15(1): 40724.
[6] Huang M Y, Tu C E, Wang S C, et al. Corylin inhibits LPS-induced inflammatory response and attenuates the activation of NLRP3 inflammasome in microglia[J]. BMC complementary and alternative medicine, 2018, 18(1): 221.
[7] Chen C C, Li H Y, Leu Y L, et al. Corylin inhibits vascular cell inflammation, proliferation and migration and reduces atherosclerosis in ApoE-deficient mice[J]. Antioxidants, 2020, 9(4): 275.
[8] Li C, Hou D, Huang Y, et al. Corylin alleviated sepsis-associated cardiac dysfunction via attenuating inflammation through downregulation of microRNA-214-5p[J]. Toxicology Research, 2024, 13(3): tfae081.
Corylin是从Psoralea corylifolia L中分离出的一种酚类化合物，具有抗炎和免疫抑制特性[1]。Corylin通过SIRT1和β3-AR调节激活棕色脂肪组织和米色脂肪细胞，发挥抗肥胖作用[2]。Corylin已被广泛用于延长代谢应激下老年小鼠的寿命、改善生理功能、减轻代谢应激并维持组织功能[3]。
在体外，Corylin处理24小时显著抑制了MCF-7细胞和MDA-MB-231细胞的增殖，IC50值分别为10.58µM和13.59µM[4]。使用10µM的Corylin处理RAW264.7细胞24小时，抑制了细胞活力和迁移[5]。用10µM 的Corylin预处理BV2细胞1小时，减轻了脂多糖（LPS）诱导的炎症反应，减少了TNF-α和IL-6的产生，并抑制了MAPK磷酸化[6]。
在体内，每日口服给予50mg/kg剂量的Corylin，持续15周，降低了高胆固醇饮食处理小鼠胸主动脉的氧化应激、VCAM-1和NOX4表达以及动脉粥样硬化斑块[7]。单次腹腔注射20mg/kg剂量的Corylin（12小时），显著减轻了LPS诱导的小鼠心功能障碍并减少了炎症[8]。
| Cell experiment [1]: | |
Cell lines | MCF-7 cells |
Preparation Method | MCF-7 cells were cultured in DMEM medium supplemented with 10% fetal bovine serum (FBS) and antibiotics (penicillin 100U/ml, streptomycin 0.1mg/ml). Cells were seeded in 6-well plates and then treated with different concentrations of Corylin (0, 2.5, 5, 10, 15, 20μM) for 24h to analyze cell viability. |
Reaction Conditions | 0, 2.5, 5, 10, 15, 20μM; 24h |
Applications | Corylin treatment decreased the cell viability of MCF-7 cells in a dose-dependent manner. |
| Animal experiment [2]: | |
Animal models | Male ApoE-deficient C57/BL6 mice |
Preparation Method | Male ApoE-deficient C57/BL6 mice (8 weeks of age) were maintained in a standard environment. Mice were randomly divided into the following three groups: group I (control group) were fed standard diet (n=12); group II (cholesterol diet group) was fed a high cholesterol diet (0.15% cholesterol) for 15 weeks (n=12); in the third group (cholesterol diet+Corylin, prevention group) mice were fed a high cholesterol diet and orally administered Corylin (50mg/kg/day) for 15 weeks (n=12). After 15 weeks, mice were euthanized with sodium pentobarbital (120mg/kg; i.p.), and the thoracic aorta was gently removed for analysis. |
Dosage form | 50mg/kg/day for 15 weeks; p.o. |
Applications | Corylin reduced oxidative stress, VCAM-1 and NOX4 expression, and atherosclerotic plaques in the thoracic aorta of cholesterol diet-treated mice. |
References: | |
| Cas No. | 53947-92-5 | SDF | |
| 别名 | 补骨脂异黄酮 | ||
| Canonical SMILES | O=C1C(C2=CC=C3C(C=CC(C)(C)O3)=C2)=COC4=CC(O)=CC=C14 | ||
| 分子式 | C20H16O4 | 分子量 | 320.34 |
| 溶解度 | DMSO : ≥ 100 mg/mL (312.17 mM);Water : < 0.1 mg/mL (insoluble) | 储存条件 | 4°C, protect from light |
| General tips | 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液；一旦配成溶液，请分装保存，避免反复冻融造成的产品失效。 储备液的保存方式和期限：-80°C 储存时，请在 6 个月内使用，-20°C 储存时，请在 1 个月内使用。 为了提高溶解度，请将管子加热至37℃，然后在超声波浴中震荡一段时间。 |
||
| Shipping Condition | 评估样品解决方案：配备蓝冰进行发货。所有其他可用尺寸：配备RT，或根据请求配备蓝冰。 | ||
| 制备储备液 | |||
 |
1 mg | 5 mg | 10 mg |
| 1 mM | 3.1217 mL | 15.6084 mL | 31.2168 mL |
| 5 mM | 624.3 μL | 3.1217 mL | 6.2434 mL |
| 10 mM | 312.2 μL | 1.5608 mL | 3.1217 mL |
| 第一步：请输入基本实验信息（考虑到实验过程中的损耗，建议多配一只动物的药量） | ||||||||||
| 给药剂量 | mg/kg |  |
动物平均体重 | g | |
每只动物给药体积 | ul | |
动物数量 | 只 |
| 第二步：请输入动物体内配方组成（配方适用于不溶于水的药物；不同批次药物配方比例不同，请联系GLPBIO为您提供正确的澄清溶液配方） | ||||||||||
| % DMSO % % Tween 80 % saline | ||||||||||
| 计算重置 | ||||||||||
计算结果:
工作液浓度： mg/ml；
DMSO母液配制方法： mg 药物溶于 μL DMSO溶液（母液浓度 mg/mL，
体内配方配制方法：取 μL DMSO母液，加入 μL PEG300，混匀澄清后加入μL Tween 80，混匀澄清后加入 μL saline，混匀澄清。
1. 首先保证母液是澄清的；
2.
一定要按照顺序依次将溶剂加入，进行下一步操作之前必须保证上一步操作得到的是澄清的溶液，可采用涡旋、超声或水浴加热等物理方法助溶。
3. 以上所有助溶剂都可在 GlpBio 网站选购。
Quality Control & SDS
- View current batch:
- Purity: >98.00% Appearance: A solid
- COA (Certificate of Analysis)
- SDS (Safety Data Sheet)
- Datasheet